Cargando…
Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A(2) Production and Granule Release, Regardless of COX-1 Activity
Platelets play crucial roles in cardiovascular diseases (CVDs) by regulating hemostasis and blood coagulation at sites of blood vessel damage. Accumulating evidence indicates daidzein inhibits platelet activation, but the mechanism involved has not been elucidated. Thus, in this study, we investigat...
Autores principales: | Hong, Hyun-Jin, Nam, Gi-Suk, Nam, Kyung-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418957/ https://www.ncbi.nlm.nih.gov/pubmed/37569361 http://dx.doi.org/10.3390/ijms241511985 |
Ejemplares similares
-
Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A(2)
por: Lucotti, Serena, et al.
Publicado: (2019) -
Derrone Inhibits Platelet Aggregation, Granule Secretion, Thromboxane A(2) Generation, and Clot Retraction: An In Vitro Study
por: Shin, Jung-Hae, et al.
Publicado: (2021) -
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project
por: Raparelli, V., et al.
Publicado: (2022) -
Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation
por: Cahill, Katherine N., et al.
Publicado: (2022) -
Thromboxane generation by human monocytes enhances platelet function
Publicado: (1986)